208 related articles for article (PubMed ID: 21036040)
1. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.
Zou Y; Albohy A; Sandbhor M; Cairo CW
Bioorg Med Chem Lett; 2010 Dec; 20(24):7529-33. PubMed ID: 21036040
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase.
Campo VL; Sesti-Costa R; Carneiro ZA; Silva JS; Schenkman S; Carvalho I
Bioorg Med Chem; 2012 Jan; 20(1):145-56. PubMed ID: 22154559
[TBL] [Abstract][Full Text] [Related]
4. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1.
Nishino R; Ikeda K; Hayakawa T; Takahashi T; Suzuki T; Sato M
Bioorg Med Chem; 2011 Apr; 19(7):2418-27. PubMed ID: 21382718
[TBL] [Abstract][Full Text] [Related]
5. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW
J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623
[TBL] [Abstract][Full Text] [Related]
6. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Nishino R; Aoyama S; Suzuki T; Sato M
Bioorg Med Chem; 2008 Jul; 16(14):6783-8. PubMed ID: 18555688
[TBL] [Abstract][Full Text] [Related]
7. Carboxylic acid-promoted copper(I)-catalyzed azide-alkyne cycloaddition.
Shao C; Wang X; Xu J; Zhao J; Zhang Q; Hu Y
J Org Chem; 2010 Oct; 75(20):7002-5. PubMed ID: 20849130
[TBL] [Abstract][Full Text] [Related]
8. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.
Tindal DJ; Dyason JC; Thomson RJ; Suzuki T; Ueyama H; Kuwahara Y; Maki N; Suzuki Y; von Itzstein M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1655-8. PubMed ID: 17236768
[TBL] [Abstract][Full Text] [Related]
10. Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide-alkyne [3 + 2] cycloaddition.
Holub JM; Kirshenbaum K
Chem Soc Rev; 2010 Apr; 39(4):1325-37. PubMed ID: 20309489
[TBL] [Abstract][Full Text] [Related]
11. Potent Inhibitors against Newcastle Disease Virus Hemagglutinin-Neuraminidase.
Rota P; La Rocca P; Piccoli M; Montefiori M; Cirillo F; Olsen L; Orioli M; Allevi P; Anastasia L
ChemMedChem; 2018 Feb; 13(3):236-240. PubMed ID: 29231283
[TBL] [Abstract][Full Text] [Related]
12. Toward analogues of MraY natural inhibitors: synthesis of 5'-triazole-substituted-aminoribosyl uridines through a Cu-catalyzed azide-alkyne cycloaddition.
Fer MJ; Olatunji S; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
J Org Chem; 2013 Oct; 78(20):10088-105. PubMed ID: 24044436
[TBL] [Abstract][Full Text] [Related]
13. Pyridine-phosphinimine ligand-accelerated Cu(I)-catalyzed azide-alkyne cycloaddition for preparation of 1-(pyridin-2-yl)-1,2,3-triazole derivatives.
Sun R; Wang H; Hu J; Zhao J; Zhang H
Org Biomol Chem; 2014 Aug; 12(31):5954-63. PubMed ID: 24984611
[TBL] [Abstract][Full Text] [Related]
14. Copper-catalyzed azide-alkyne cycloaddition: regioselective synthesis of 1,4,5-trisubstituted 1,2,3-triazoles.
Spiteri C; Moses JE
Angew Chem Int Ed Engl; 2010; 49(1):31-3. PubMed ID: 19921729
[No Abstract] [Full Text] [Related]
15. Metal chelating systems synthesized using the copper(I) catalyzed azide-alkyne cycloaddition.
Struthers H; Mindt TL; Schibli R
Dalton Trans; 2010 Jan; 39(3):675-96. PubMed ID: 20066208
[TBL] [Abstract][Full Text] [Related]
16. Copper(II)/copper(I)-catalyzed aza-Michael addition/click reaction of in situ generated alpha-azidohydrazones: synthesis of novel pyrazolone-triazole framework.
Attanasi OA; Favi G; Filippone P; Mantellini F; Moscatelli G; Perrulli FR
Org Lett; 2010 Feb; 12(3):468-71. PubMed ID: 20043624
[TBL] [Abstract][Full Text] [Related]
17. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.
Pardin C; Roy I; Lubell WD; Keillor JW
Chem Biol Drug Des; 2008 Sep; 72(3):189-96. PubMed ID: 18715232
[TBL] [Abstract][Full Text] [Related]
18. Cu-catalyzed azide-alkyne cycloaddition.
Meldal M; Tornøe CW
Chem Rev; 2008 Aug; 108(8):2952-3015. PubMed ID: 18698735
[No Abstract] [Full Text] [Related]
19. Synthesis of 2,2,4-trimethyl-1,2-dihydroquinolinyl substituted 1,2,3-triazole derivatives: their evaluation as potential PDE 4B inhibitors possessing cytotoxic properties against cancer cells.
Praveena KS; Durgadas S; Suresh Babu N; Akkenapally S; Ganesh Kumar C; Deora GS; Murthy NY; Mukkanti K; Pal S
Bioorg Chem; 2014 Apr; 53():8-14. PubMed ID: 24463218
[TBL] [Abstract][Full Text] [Related]
20. Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization.
Whiting M; Tripp JC; Lin YC; Lindstrom W; Olson AJ; Elder JH; Sharpless KB; Fokin VV
J Med Chem; 2006 Dec; 49(26):7697-710. PubMed ID: 17181152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
